Zavedos (idarubicin): Reviews and patient testimonials

Zavedos 10 mg Capsules

Acute non-lymphocytic leukaemia (ANLL).

Whenever intravenous idarubicin cannot be employed e.g. for medical, psychological or social reasons, oral idarubicin can be used for remission induction in patients with previously untreated, relapsed or refractory acute non-lymphocytic leukaemia.

Zavedos may be used in combination chemotherapy regimens involving other cytotoxic agents.

As a single agent in the treatment of advanced breast cancer after failure of front line chemotherapy not including anthracyclines.

Zavedos 10 mg Powder for Solution for Injection

Adults

For the treatment of acute myeloid leukaemia (AML), for remission induction in untreated patients or for remission induction in relapsed or refractory patients.

For second line treatment of relapsed acute lymphoblastic leukaemia (ALL).

Children

For first line treatment of acute myeloid leukaemia (AML), in combination with cytarabine, for remission induction.

For second line treatment of relapsed acute lymphoblastic leukaemia (ALL).

Zavedos may be used in combination chemotherapy regimens involving other cytotoxic agents.

Zavedos 5mg Capsules

Whenever intravenous idarubicin cannot be employed e.g. for medical, psychological or social reasons, oral idarubicin can be used for remission induction in patients with previously untreated, relapsed or refractory acute non-lymphocytic leukaemia.

Zavedos may be used in combination chemotherapy regimens involving other cytotoxic agents.

As a single agent in the treatment of advanced breast cancer after failure of front line chemotherapy not including anthracyclines.

Zavedos 5mg Powder for Solution for Injection

Adults

For the treatment of acute myeloid leukaemia (AML), for remission induction in untreated patients or for remission induction in relapsed or refractory patients.

For second line treatment of relapsed acute lymphoblastic leukaemia (ALL).

Children

For first line treatment of acute myeloidleukaemia (AML), in combination with cytarabine, for remission induction.

For second line treatment of relapsed acute lymphoblastic leukaemia (ALL).

Zavedos may be used in combination chemotherapy regimens involving other cytotoxic agents.

Route of administration: Injectable, Oral
Molecule: idarubicin